White label ELPA - ClinicalTrials.eu

Study on Optimizing Initial Dosing of Flucloxacillin and Drug Combination for Critically Ill Patients with Sepsis in the ICU

Recruiting

3 1 1 1
Investigated diseases:
- Sepsis
Investigated drugs:
Study on the Effects of GSL-01-001 for Patients with Irritable Bowel Syndrome (IBS) Type D

Recruiting

2 1 1
Investigated diseases:
- Irritable bowel syndrome
Investigated drugs:
- Cannabidiol
Study Comparing Bomedemstat and Hydroxycarbamide for Patients with Essential Thrombocythemia

Recruiting

3 1 1
Investigated diseases:
- Essential thrombocythaemia
Investigated drugs:
- Bomedemstat
- Hydroxycarbamide
+3
Study on the Effects of Rapcabtagene Autoleucel in Patients with Systemic Lupus Erythematosus and Active, Refractory Lupus Nephritis

Recruiting

2 1 1 1
Investigated diseases:
- Lupus nephritis
- Systemic lupus erythematosus
Investigated drugs:
+7
Study on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Recruiting

3 1 1 1
Investigated diseases:
- Breast cancer
Investigated drugs:
+4
Study on the Effectiveness of Autologous Adipose-Derived Stromal Vascular Fraction Cells for Patients with Scarred Vocal Folds

Recruiting

2 1
Investigated drugs:
- Autologous Adipose Tissue-Derived Stromal Vascular Fraction Cells
- Human Serum Albumin 5%
Study to Test if Zelpultide Alfa Helps Prevent Lung Disease in High-Risk Premature Babies

Recruiting

4 1
Investigated drugs:
- Recombinant Human Surfactant Protein-D
+2
Imaging Study with 89Zr-Bevacizumab for Predicting Treatment Effects in Patients with NF2-Related Schwannomatosis

Recruiting

2 1 1
Investigated diseases:
- Neurofibromatosis
Investigated drugs:
- Bevacizumab Zirconium Zr-89
Evaluating SGM-101 (fluorochrome-labeled antibody) in patients with locally advanced or recurrent rectal cancer undergoing surgery

Recruiting

2 1 1
Investigated diseases:
- Rectal cancer
Investigated drugs:
- Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen Conjugated To Fluorochrome Bm-104
Study of Pembrolizumab with Etoposide and Cisplatin for First-Line Treatment in Patients with Small Cell Ovarian Cancer

Recruiting

2 1 1 1
Investigated diseases:
- Ovarian cancer
Investigated drugs:
- Cyclophosphamide

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies